The Effects of Mirtoselect®, Virtiva®, and Enovita® on Cognitive Performance and Mood States
Completed · Not applicable · Has a placebo group
Conditions studied: Mental Processes, Cognitive Change, Mood Change
In brief
This is a randomized, double-blind, placebo-controlled, 4-week intervention clinical study assessing the efficacy of Mirtoselect®, Virtiva® Plus, and Enovita® on cognitive performance and mood states, and the occurrence of adverse events in response to daily supplementation. The desired sample size for this study is 64 subjects. To account for potential dropouts, we aim to enroll up to 20% over the desired sample size. Therefore, this study will enroll up to 76 healthy men and women (25-55 years of age). Subjects will be randomly divided into four study groups: Placebo, Virtiva® ginkgo biloba extract, Mirtoselect® bilberry extract, or Enovita® grape seed extract. Blocked randomization will be deployed in which subjects are divided into blocks of 4 subjects and each subject within a block is randomly assigned to one of the four study groups.
Key facts
- Study ID
- NCT06309914
- Run by
- Applied Science & Performance Institute
- People needed
- 76
- Starts
- 2024-02-21
- Expected to finish
- 2024-07-08
- Last updated by the study team
- 2024-07-30
Who can join
Age: 25 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Aged 25 to 55 years
- Willing and able to give written informed consent
- Able to read, understand, sign and date the informed consent document (English only)
- Able and willing to comply with the schedule visit(s) and study requirements.
You may not qualify if…
- Developmental disability or cognitive impairment that would preclude adequate comprehension of the informed consent form and/or ability to follow study subject requirements and/or record the necessary study measurements.
- History of cardiovascular disease
- History of neurological disorders
- History of gastrointestinal disorders that could lead to uncertain absorption of the study supplements
- History of kidney or liver disease
- History of metabolic disorders (diabetes, metabolic syndrome, other)
- History or current malignancy
- Receiving chemotherapy agents or radiation treatments
- Diagnosis of a terminal illness
- Pregnancy or has breastfed within 3 months prior to enrollment
- Use of prescription medications that impact digestion
- History or current alcohol or drug abuse
- Has significant concurrent illnesses (controlled or uncontrolled)
- Participation in any other investigational study within 30 days prior to consent
Where it is running
- Applied Science and Performance Institute — Tampa, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.